JavaScript NENÍ povolen !

Prosím povolte JavaScript.

Článek

PubMed

Záznam pochází z PubMed

COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma

Arenbergerova, M
Autor Arenbergerova, M Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic
Gkalpakiotis, S
Autor Gkalpakiotis, S ORCID Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic
Arenberger, P
Autor Arenberger, P Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic
Fialova, A
Autor Fialova, A Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic
Pasek, M
Autor Pasek, M Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic

The Journal of dermatological treatment. 2022 May ; 33 (3) : 1782-1783. [epub] 20201022

J Dermatolog Treat
ISSN 1471-1753 | 0954-6634
Zdroj

Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic

Typ dokumentu dopisy

Perzistentní odkaz https://www.medvik.cz/link/pmid33092421

PubMed 33092421
DOI 10.1080/09546634.2020.1822500
Knihovny.cz E-zdroje

MeSH
COVID-19 * MeSH
inhibitory kontrolních bodů škodlivé účinky MeSH
lidé MeSH
melanom * farmakoterapie MeSH
nádory kůže * farmakoterapie MeSH
Check Tag
lidé MeSH
Publikační typ
dopisy MeSH
Názvy látek
inhibitory kontrolních bodů MeSH

Department of Dermatovenereology 3rd Faculty of Medicine Charles University and Kralovske Vinohrady University Hospital Prague Czech Republic

Citace poskytuje Crossref.org

Najít záznam

v BMČ

Citační ukazatele